Vericel (VCEL) Enterprise Value Growth (5y) (2017 - 2026)
Vericel (VCEL) Enterprise Value Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.71% |
| Dec 31, 2025 | -12.65% |
| Sep 30, 2025 | -9.62% |
| Jun 30, 2025 | -7.66% |
| Mar 31, 2025 | -6.71% |
| Dec 31, 2024 | -4.06% |
| Sep 30, 2024 | 1.18% |
| Jun 30, 2024 | -2.82% |
| Mar 31, 2024 | -5.64% |
| Dec 31, 2023 | -0.93% |
| Sep 30, 2023 | 3.09% |
| Jun 30, 2023 | -0.60% |
| Dec 31, 2022 | -34.79% |
| Dec 31, 2019 | -18.10% |
| Sep 30, 2019 | -14.72% |
| Jun 30, 2019 | -55.33% |
| Dec 31, 2018 | -59.40% |
| Sep 30, 2018 | -55.31% |
| Jun 30, 2018 | -84.07% |
| Dec 31, 2017 | -14.52% |